Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.
about
Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivoRegulation of E-box DNA binding during in vivo and in vitro activation of rat and human hepatic stellate cellsDifferential expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in thioacetamide-induced chronic liver injury.Is liver fibrosis reversible?Molecular mechanism of the reversibility of hepatic fibrosis: with special reference to the role of matrix metalloproteinases.Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma.Liver fibrosis.Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism.Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.Epimorphin alters the inhibitory effects of SOX9 on Mmp13 in activated hepatic stellate cells.Evidence for altered hepatic matrix degradation in genetic haemochromatosis.Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.TGF-beta dependent regulation of oxygen radicals during transdifferentiation of activated hepatic stellate cells to myofibroblastoid cellsModels of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosisHepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation.NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells.Methodologic research on TIMP-1, TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance.Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis.Matrix metalloproteinase gene delivery for liver fibrosisRegulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells.Current status and future prospects of mesenchymal stem cell therapy for liver fibrosisPerformance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian childrenCollagenous sprue: a case report and literature review.Liver fibrosis: a bidirectional model of fibrogenesis and resolution.Preparing the ground for tissue regeneration: from mechanism to therapy.Syncoilin is an intermediate filament protein in activated hepatic stellate cells.Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitorsEffects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE.Hepatocyte-matrix interactions.Establishment of a new human cell line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells.Iron overload and liver fibrosis.Fibrodynamics-elucidation of the mechanisms and sites of liver fibrogenesisButein inhibits ethanol-induced activation of liver stellate cells through TGF-β, NFκB, p38, and JNK signaling pathways and inhibition of oxidative stress.Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 expression in fibrotic rat liver.Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis.Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma.A red wine polyphenolic extract reduces the activation phenotype of cultured human liver myofibroblasts.Perisinusoidal lipocytes and fibrogenesis.
P2860
Q28353986-05D5EF3A-09F1-4E12-B0D9-7D64B709A445Q28361630-1EB73FB0-027C-4FB9-A197-2BA93AB37F16Q33749918-87153683-66D8-4589-932C-A0C1D941DA2DQ33862568-5021FE86-1807-4126-B1C0-A5C7AEDD114DQ33888050-59CF1D63-F6ED-4D1B-B3F5-97EAC737C2D2Q33888088-C35B8110-10C0-4F58-B9DE-0E65EDB71A0CQ34005628-A361ABE2-54A8-4258-8106-521372BF85D7Q34078665-39207381-99F8-47A4-A41F-B3447EF62802Q34992341-76B06206-0346-4281-9719-37FF06B8DC8FQ35196346-D9B8002A-5F14-4A77-BD37-BED0135DE431Q35350790-69BFD29B-8E5F-4DDD-AC79-2C68B2864AA1Q35598320-90B12DB3-2CAD-4AC8-AAA0-CD26A66373A7Q35649173-36983FC8-A3A8-446E-B118-9FA562FB2685Q35649446-2D5BE567-6A83-4953-8B6E-6651CFA646ACQ35764453-49DD8767-863E-43D4-8F13-DDBD4C860A24Q35810015-76A0EE12-A53D-42F5-B286-C29B85F72819Q36301409-8BC80318-7459-45B5-9D54-B9E885AD089AQ36316076-7AC54DB2-C562-4DFE-81D2-9311B2B79A20Q36397399-81AFB499-3660-4799-B597-AD7EE809621CQ36852793-07F263FE-F016-43C1-B973-E49D46478EC5Q36942777-3E380A87-51A5-47F4-82EE-C7E94E78ACD4Q37430773-C569E95B-810A-442D-BE45-8E2971E8E2DCQ37675175-2F8362D9-4B31-4162-BE9D-125BB1BE7E0DQ37767358-A7311ED9-B60A-45C1-ABB6-F138D116521AQ38014650-FB489748-A0FE-4EF1-8EE5-14FC788EA066Q38237617-4FCA09FA-9C98-469D-A1A0-0631A7EAC497Q39094831-00C912DE-EE0B-4894-8C00-F95C1DFF98A7Q39807542-C067097A-3F55-4E78-AD03-EBDA9EC34466Q40437095-56FBB3BE-761C-4BA9-8CFF-7540F71D13D0Q40666351-EACCC4D6-C24A-4B86-BD49-A1B8386C5233Q41233366-70673F23-F618-4A2B-9587-7CDAC944A0A3Q41349882-A38DCB8A-C10A-4A9A-AED2-BDCD8012D866Q41825545-42A54FA1-CCB6-46E5-B1F8-7FE9C6EEEC96Q42056048-269ABDC9-F55A-4069-B241-1CFD6B9643BDQ42131078-981FC97A-266F-4FF6-9768-CDB8E8E02C46Q42132079-397C335E-C9A1-4519-A181-A710FBB41956Q42151300-7BD99667-DF9C-43B5-BC5E-03E5632D6C93Q43037592-43B41A2E-7604-4080-8690-57D4C4E5BF44Q43103713-A8FB858F-D87F-423F-A56B-A8BD7E338239Q43214112-3C414A84-20EB-47C5-A869-0C2257720583
P2860
Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Human hepatic lipocytes synthe ...... f matrix degradation in liver.
@ast
Human hepatic lipocytes synthe ...... f matrix degradation in liver.
@en
type
label
Human hepatic lipocytes synthe ...... f matrix degradation in liver.
@ast
Human hepatic lipocytes synthe ...... f matrix degradation in liver.
@en
prefLabel
Human hepatic lipocytes synthe ...... f matrix degradation in liver.
@ast
Human hepatic lipocytes synthe ...... f matrix degradation in liver.
@en
P2093
P2860
P356
P1476
Human hepatic lipocytes synthe ...... f matrix degradation in liver.
@en
P2093
J P Iredale
M J Arthur
R M Hembry
S L Friedman
P2860
P304
P356
10.1172/JCI115850
P407
P577
1992-07-01T00:00:00Z